⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 19, 2014Journal of Crohn s and ColitisOpen Access

Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease

Ashwin N. Ananthakrishnan Andrew Cagan Vivian S. Gainer Su-Chun Cheng Tianxi Cai Peter Szolovits Stanley Y. Shaw Susanne Churchill Elizabeth W. Karlson Shawn N. Murphy Isaac S. Kohane Katherine P. Liao

View Full Paper

Ask AI

Bookmark

Share

Abstract

PSC is associated with increased risk of colorectal and pancreatobiliary cancer but not with excess risk of other solid organ cancers.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ananthakrishnan et al. (2014) studied this question.

synapsesocial.com/papers/69d8f9a12c87b79b92d18911 https://doi.org/10.1016/j.crohns.2014.01.019

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mortality in inflammatory bowel disease in the Netherlands 1991–2002Retrospective Study · 2009 · 56 citations
2Cause-Specific Mortality and 30-year Relative Survival of Crohnʼs Disease and Ulcerative ColitisCohort Study · 2013 · 52 citations
3Mortality from Inflammatory Bowel DiseasesCohort Study · 2012 · 45 citations
4Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort StudyRegistry Study · 2013 · 243 citations
5Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort StudiesMeta-Analysis · 2010 · 277 citations

More related papers

Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease2012
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis2004
Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease2012

More from Journal of Crohn s and Colitis

Plasma lipopolysaccharide-binding protein (LBP), a proxy for intestinal permeability, relates to clinicopathological and immunological disease activity in inflammatory bowel disease patients at diagnosis and during disease courseMon,
Targeting epithelial IFN-I signaling restores barrier integrity in anti-TNF refractory Crohn’s diseaseTue,